RxDoctor Payments Data

Harriet Jones, MD

Internal Medicine · Jackson, MSNPI 1184672750

Payments from drug & device makers

$2,322in general payments, 2019–2025

Across 137 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$557
  • AbbVie$248
  • Lilly USA, LLC$208
  • Amgen$199
  • Boehringer Ingelheim$171
  • Edwards Lifesciences$167
  • plus $772 from 23 others

What the payments were for

  • Food & beverage$2,322100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,322 in reported general payments places this provider in the 75th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$232,263
Medicare patients
310
Services billed
3,792

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$77,272
JardianceEmpagliflozin72$69,771
TrulicityDulaglutide46$52,540
OzempicSemaglutide20$25,194
MounjaroTirzepatide22$24,452
XareltoRivaroxaban31$20,775
LinzessLinaclotide11$16,290
JanumetSitagliptin Phos/Metformin Hcl18$14,167
FarxigaDapagliflozin Propanediol11$12,247
Aimovig AutoinjectorErenumab-Aooe14$9,993
Tresiba Flextouch U-200Insulin Degludec17$8,941
SynthroidLevothyroxine Sodium64$6,758
Tresiba Flextouch U-100Insulin Degludec13$6,256
Rosuvastatin Calcium228$2,031
Metoprolol Succinate104$1,989

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$96$77,27269 claims
Lilly USA, LLCTrulicity, Mounjaro$208$76,99268 claims
Boehringer IngelheimJardiance$171$69,77172 claims
Novo NordiskOzempic$557$25,19420 claims
AbbVieLinzess, Synthroid$248$23,04875 claims
MerckJanumet$12$14,16718 claims
AstraZenecaFarxiga$85$12,24711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →